- TRADE NAME: Crestor (AstraZeneca)
- INDICATIONS: Hypercholesterolemia, mixed dyslipidemia
- CLASS: HMG-CoA reductase inhibitor / statin
- HALF-LIFE: ~19 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Amiodarone, Antacids, Atazanavir, Ciprofibrate, Colchicine, Conivaptan, Coumarins, Cyclosporine, Daptomycin, Darunavir, Dronedarone, Elbasvir & Grazoprevir, Eltrombopag, Eluxadoline, Erythromycin, Ethinylestradiol, Fenofibrate, Fibrates, Fosamprenavir, Fusidic Acid, Gemfibrozil, Indinavir, Ledipasvir & Sofosbuvir, Letermovir, Lopinavir, Nelfinavir, Niacin, Niacinamide, Phenindione, Progestins, Protease inhibitors, Ritonavir, Safinamide, Saquinavir, Sofosbuvir/Velpatasvir/Voxilaprevir, Tafamidis meglumine, Tipranavir, Trabectedin, Vitamin K antagonists, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of rosuvastatin in the Informa Healthcare journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 12/19/2023
